{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:47:38Z","timestamp":1770972458087,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2011,12,14]],"date-time":"2011-12-14T00:00:00Z","timestamp":1323820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Arch Psychiatry Clin Neurosci"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1007\/s00406-011-0282-7","type":"journal-article","created":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T01:49:08Z","timestamp":1323740948000},"page":"365-374","source":"Crossref","is-referenced-by-count":23,"title":["Reduced density of hypothalamic VGF-immunoreactive neurons in schizophrenia: a potential link to impaired growth factor signaling and energy homeostasis"],"prefix":"10.1007","volume":"262","author":[{"given":"Stefan","family":"Busse","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans-Gert","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy","family":"Busse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hendrik","family":"Bielau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf","family":"Brisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mawrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zolt\u00e1n","family":"Sarnyai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Gos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernhard","family":"Bogerts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,12,14]]},"reference":[{"key":"282_CR1","doi-asserted-by":"crossref","first-page":"10800","DOI":"10.1523\/JNEUROSCI.23-34-10800.2003","volume":"23","author":"J Alder","year":"2003","unstructured":"Alder J, Thakker-Varia S, Bangasser DA, Kuroiwa M, Plummer MR, Shors TJ, Black IB (2003) Brain-derived neurotrophic factor-induced gene expression reveals novel actions of vgf in hippocampal synaptic plasticity. J Neurosci 23:10800\u201310808","journal-title":"J Neurosci"},{"key":"282_CR2","volume-title":"Diagnostic and statistical manual of mental disorders, 4th revised edition (dsm-iv-tr)","author":"APA","year":"2000","unstructured":"APA (2000) Diagnostic and statistical manual of mental disorders, 4th revised edition (dsm-iv-tr). American Psychiatric Press, Washington, DC"},{"key":"282_CR3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.neuroscience.2010.06.057","volume":"170","author":"A Bartolomucci","year":"2010","unstructured":"Bartolomucci A, Pasinetti GM, Salton SR (2010) Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders. Neuroscience 170:289\u2013297","journal-title":"Neuroscience"},{"key":"282_CR4","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s12263-007-0047-0","volume":"2","author":"A Bartolomucci","year":"2007","unstructured":"Bartolomucci A, Possenti R, Levi A, Pavone F, Moles A (2007) The role of the vgf gene and vgf-derived peptides in nutrition and metabolism. Genes Nutr 2:169\u2013180","journal-title":"Genes Nutr"},{"key":"282_CR5","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2174\/1876528901003010059","volume":"3","author":"HG Bernstein","year":"2010","unstructured":"Bernstein HG, Keilhoff G, Steiner J, Dobrowolny H, Bogerts B (2010) The hypothalamus in schizophrenia research: No longer a wallflower existence. The Open Neuroendocrinol J 3:59\u201367","journal-title":"The Open Neuroendocrinol J"},{"key":"282_CR6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0306-4522(97)00461-2","volume":"83","author":"HG Bernstein","year":"1998","unstructured":"Bernstein HG, Stanarius A, Baumann B, Henning H, Krell D, Danos P, Falkai P, Bogerts B (1998) Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics. Neuroscience 83:867\u2013875","journal-title":"Neuroscience"},{"key":"282_CR7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00406-010-0119-9","volume":"261","author":"R Brisch","year":"2011","unstructured":"Brisch R, Bernstein HG, Dobrowolny H, Krell D, Stauch R, Trubner K, Steiner J, Ghabriel MN, Bielau H, Wolf R, Winter J, Kropf S, Gos T, Bogerts B (2011) A morphometric analysis of the septal nuclei in schizophrenia and affective disorders: reduced neuronal density in the lateral septal nucleus in bipolar disorder. Eur Arch Psychiatry Clin Neurosci 261:47\u201358","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"282_CR8","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1469-7580.2010.01309.x","volume":"217","author":"C Cocco","year":"2010","unstructured":"Cocco C, D\u2019Amato F, Noli B, Ledda A, Brancia C, Bongioanni P, Ferri GL (2010) Distribution of vgf peptides in the human cortex and their selective changes in parkinson\u2019s and alzheimer\u2019s diseases. J Anat 217:683\u2013693","journal-title":"J Anat"},{"key":"282_CR9","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.ijdevneu.2011.02.013","volume":"29","author":"G Faludi","year":"2011","unstructured":"Faludi G, Mirnics K (2011) Synaptic changes in the brain of subjects with schizophrenia. Int J Dev Neurosci 29:305\u2013309","journal-title":"Int J Dev Neurosci"},{"key":"282_CR10","doi-asserted-by":"crossref","unstructured":"Ferri GL, Noli B, Brancia C, D\u2019Amato F, Cocco C (2011) Vgf: An inducible gene product, precursor of a diverse array of neuro-endocrine peptides and tissue-specific disease biomarkers. J Chem Neuroanat","DOI":"10.1016\/j.jchemneu.2011.05.007"},{"key":"282_CR11","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/sj.mp.4001081","volume":"7","author":"T Futamura","year":"2002","unstructured":"Futamura T, Toyooka K, Iritani S, Niizato K, Nakamura R, Tsuchiya K, Someya T, Kakita A, Takahashi H, Nawa H (2002) Abnormal expression of epidermal growth factor and its receptor in the forebrain and serum of schizophrenic patients. Mol Psychiatry 7:673\u2013682","journal-title":"Mol Psychiatry"},{"key":"282_CR12","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1038\/mp.2010.88","volume":"16","author":"MJ Green","year":"2011","unstructured":"Green MJ, Matheson SL, Shepherd A, Weickert CS, Carr VJ (2011) Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-analysis. Mol Psychiatry 16:960\u2013972","journal-title":"Mol Psychiatry"},{"key":"282_CR13","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1016\/j.psyneuen.2010.12.018","volume":"36","author":"PC Guest","year":"2011","unstructured":"Guest PC, Schwarz E, Krishnamurthy D, Harris LW, Leweke FM, Rothermundt M, van Beveren NJ, Spain M, Barnes A, Steiner J, Rahmoune H, Bahn S (2011) Altered levels of circulating insulin and other neuroendocrine hormones associated with the onset of schizophrenia. Psychoneuroendocrinology 36:1092\u20131096","journal-title":"Psychoneuroendocrinology"},{"key":"282_CR14","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/mp.2009.81","volume":"15","author":"PC Guest","year":"2010","unstructured":"Guest PC, Wang L, Harris LW, Burling K, Levin Y, Ernst A, Wayland MT, Umrania Y, Herberth M, Koethe D, van Beveren NJ, Rothermundt M, McAllister G, Leweke FM, Steiner J, Bahn S (2010) Increased levels of circulating insulin-related peptides in first onset, antipsychotic naive schizophrenia patients. Mol Psychiatry 15:118\u2013119","journal-title":"Mol Psychiatry"},{"key":"282_CR15","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1523\/JNEUROSCI.22-16-06929.2002","volume":"22","author":"S Hahm","year":"2002","unstructured":"Hahm S, Fekete C, Mizuno TM, Windsor J, Yan H, Boozer CN, Lee C, Elmquist JK, Lechan RM, Mobbs CV, Salton SR (2002) Vgf is required for obesity induced by diet, gold thioglucose treatment, and agouti and is differentially regulated in pro-opiomelanocortin- and neuropeptide y-containing arcuate neurons in response to fasting. J Neurosci 22:6929\u20136938","journal-title":"J Neurosci"},{"key":"282_CR16","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/30.10.6182185","volume":"30","author":"SM Hsu","year":"1982","unstructured":"Hsu SM, Soban E (1982) Color modification of diaminobenzidine (dab) precipitation by metallic ions and its application for double immunohistochemistry. J Histochem Cytochem 30:1079\u20131082","journal-title":"J Histochem Cytochem"},{"key":"282_CR17","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1371\/journal.pmed.0030428","volume":"3","author":"JT Huang","year":"2006","unstructured":"Huang JT, Leweke FM, Oxley D, Wang L, Harris N, Koethe D, Gerth CW, Nolden BM, Gross S, Schreiber D, Reed B, Bahn S (2006) Disease biomarkers in cerebrospinal fluid of patients with first-onset psychosis. PLoS Med 3:e428","journal-title":"PLoS Med"},{"key":"282_CR18","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000127319","volume":"88","author":"PH Jethwa","year":"2008","unstructured":"Jethwa PH, Ebling FJ (2008) Role of vgf-derived peptides in the control of food intake, body weight and reproduction. Neuroendocrinology 88:80\u201387","journal-title":"Neuroendocrinology"},{"key":"282_CR19","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00406-009-0033-1","volume":"260","author":"G Keilhoff","year":"2010","unstructured":"Keilhoff G, Grecksch G, Bernstein HG, Roskoden T, Becker A (2010) Risperidone and haloperidol promote survival of stem cells in the rat hippocampus. Eur Arch Psychiatry Clin Neurosci 260:151\u2013162","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"282_CR20","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1126\/science.3839317","volume":"229","author":"A Levi","year":"1985","unstructured":"Levi A, Eldridge JD, Paterson BM (1985) Molecular cloning of a gene sequence regulated by nerve growth factor. Science 229:393\u2013395","journal-title":"Science"},{"key":"282_CR21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1023\/B:CEMN.0000023627.79947.22","volume":"24","author":"A Levi","year":"2004","unstructured":"Levi A, Ferri GL, Watson E, Possenti R, Salton SR (2004) Processing, distribution, and function of vgf, a neuronal and endocrine peptide precursor. Cell Mol Neurobiol 24:517\u2013533","journal-title":"Cell Mol Neurobiol"},{"key":"282_CR22","volume-title":"Atlas of the human brain","author":"JK Mai","year":"2003","unstructured":"Mai JK, Assheuer J, Paxinos G (2003) Atlas of the human brain. Academic Press, San Diego"},{"issue":"4","key":"282_CR23","first-page":"8","volume":"68","author":"JW Newcomer","year":"2007","unstructured":"Newcomer JW (2007) Antipsychotic medications: metabolic and cardiovascular risk. J Clin Psychiatry 68(4):8\u201313","journal-title":"J Clin Psychiatry"},{"key":"282_CR24","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/sj.mp.4001791","volume":"11","author":"A Reif","year":"2006","unstructured":"Reif A, Fritzen S, Finger M, Strobel A, Lauer M, Schmitt A, Lesch KP (2006) Neural stem cell proliferation is decreased in schizophrenia, but not in depression. Mol Psychiatry 11:514\u2013522","journal-title":"Mol Psychiatry"},{"key":"282_CR25","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.expneurol.2005.08.002","volume":"196","author":"U Ruetschi","year":"2005","unstructured":"Ruetschi U, Zetterberg H, Podust VN, Gottfries J, Li S, Hviid Simonsen A, McGuire J, Karlsson M, Rymo L, Davies H, Minthon L, Blennow K (2005) Identification of csf biomarkers for frontotemporal dementia using seldi-tof. Exp Neurol 196:273\u2013281","journal-title":"Exp Neurol"},{"key":"282_CR26","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.psyneuen.2003.08.011","volume":"29","author":"MC Ryan","year":"2004","unstructured":"Ryan MC, Sharifi N, Condren R, Thakore JH (2004) Evidence of basal pituitary-adrenal overactivity in first episode, drug naive patients with schizophrenia. Psychoneuroendocrinology 29:1065\u20131070","journal-title":"Psychoneuroendocrinology"},{"key":"282_CR27","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1055\/s-2006-925346","volume":"38","author":"EV Sivukhina","year":"2006","unstructured":"Sivukhina EV, Jirikowski GF, Bernstein HG, Lewis JG, Herbert Z (2006) Expression of corticosteroid-binding protein in the human hypothalamus, co-localization with oxytocin and vasopressin. Horm Metab Res 38:253\u2013259","journal-title":"Horm Metab Res"},{"key":"282_CR28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/(SICI)1096-9861(19980427)394:1<91::AID-CNE7>3.0.CO;2-C","volume":"394","author":"SE Snyder","year":"1998","unstructured":"Snyder SE, Salton SR (1998) Expression of vgf mrna in the adult rat central nervous system. J Comp Neurol 394:91\u2013105","journal-title":"J Comp Neurol"},{"key":"282_CR29","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1016\/j.jpsychires.2007.10.001","volume":"42","author":"J Steiner","year":"2008","unstructured":"Steiner J, Bernstein HG, Bielau H, Farkas N, Winter J, Dobrowolny H, Brisch R, Gos T, Mawrin C, Myint AM, Bogerts B (2008) S100b-immunopositive glia is elevated in paranoid as compared to residual schizophrenia: a morphometric study. J Psychiatr Res 42:868\u2013876","journal-title":"J Psychiatr Res"},{"key":"282_CR30","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s00401-006-0090-8","volume":"112","author":"J Steiner","year":"2006","unstructured":"Steiner J, Mawrin C, Ziegeler A, Bielau H, Ullrich O, Bernstein HG, Bogerts B (2006) Distribution of hla-dr-positive microglia in schizophrenia reflects impaired cerebral lateralization. Acta Neuropathol 112:305\u2013316","journal-title":"Acta Neuropathol"},{"key":"282_CR31","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/schbul\/sbp033","volume":"36","author":"AF Terwisscha van Scheltinga","year":"2010","unstructured":"Terwisscha van Scheltinga AF, Bakker SC, Kahn RS (2010) Fibroblast growth factors in schizophrenia. Schizophr Bull 36:1157\u20131166","journal-title":"Schizophr Bull"},{"key":"282_CR32","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.bbr.2008.10.006","volume":"197","author":"S Thakker-Varia","year":"2009","unstructured":"Thakker-Varia S, Alder J (2009) Neuropeptides in depression: role of vgf. Behav Brain Res 197:262\u2013278","journal-title":"Behav Brain Res"},{"key":"282_CR33","doi-asserted-by":"crossref","first-page":"S76","DOI":"10.1192\/bjp.184.47.s76","volume":"47","author":"JH Thakore","year":"2004","unstructured":"Thakore JH (2004) Metabolic disturbance in first-episode schizophrenia. Br J Psychiatry Suppl 47:S76\u2013S79","journal-title":"Br J Psychiatry Suppl"},{"key":"282_CR34","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1080\/10398560701636906","volume":"15","author":"S Tirupati","year":"2007","unstructured":"Tirupati S, Chua LE (2007) Body mass index as a screening test for metabolic syndrome in schizophrenia and schizoaffective disorders. Australas Psychiatry 15:470\u2013473","journal-title":"Australas Psychiatry"},{"key":"282_CR35","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1046\/j.1471-4159.1995.65062441.x","volume":"65","author":"E Trani","year":"1995","unstructured":"Trani E, Ciotti T, Rinaldi AM, Canu N, Ferri GL, Levi A, Possenti R (1995) Tissue-specific processing of the neuroendocrine protein vgf. J Neurochem 65:2441\u20132449","journal-title":"J Neurochem"},{"key":"282_CR36","doi-asserted-by":"crossref","first-page":"4122","DOI":"10.1523\/JNEUROSCI.09-12-04122.1989","volume":"9","author":"AN Pol van den","year":"1989","unstructured":"van den Pol AN, Decavel C, Levi A, Paterson B (1989) Hypothalamic expression of a novel gene product, vgf: Immunocytochemical analysis. J Neurosci 9:4122\u20134137","journal-title":"J Neurosci"},{"key":"282_CR37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.neulet.2008.04.027","volume":"440","author":"HE Vargas","year":"2008","unstructured":"Vargas HE, Gama CS, Andreazza AC, Medeiros D, Stertz L, Fries G, Palha J, Cereser KM, Berk M, Kapczinski F, Belmonte-de-Abreu PS (2008) Decreased serum neurotrophin 3 in chronically medicated schizophrenic males. Neurosci Lett 440:197\u2013201","journal-title":"Neurosci Lett"},{"key":"282_CR38","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/1472-6793-9-19","volume":"9","author":"E Watson","year":"2009","unstructured":"Watson E, Fargali S, Okamoto H, Sadahiro M, Gordon RE, Chakraborty T, Sleeman MW, Salton SR (2009) Analysis of knockout mice suggests a role for vgf in the control of fat storage and energy expenditure. BMC Physiol 9:19","journal-title":"BMC Physiol"},{"key":"282_CR39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00406-010-0118-x","volume":"261","author":"MK Yazici","year":"2011","unstructured":"Yazici MK, Anil Yagcioglu AE, Ertugrul A, Eni N, Karahan S, Karaagaoglu E, Tokgozoglu SL (2011) The prevalence and clinical correlates of metabolic syndrome in patients with schizophrenia: findings from a cohort in turkey. Eur Arch Psychiatry Clin Neurosci 261:69\u201378","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"282_CR40","doi-asserted-by":"crossref","first-page":"92","DOI":"10.7150\/ijms.5.92","volume":"5","author":"Z Zhao","year":"2008","unstructured":"Zhao Z, Lange DJ, Ho L, Bonini S, Shao B, Salton SR, Thomas S, Pasinetti GM (2008) Vgf is a novel biomarker associated with muscle weakness in amyotrophic lateral sclerosis (als), with a potential role in disease pathogenesis. Int J Med Sci 5:92\u201399","journal-title":"Int J Med Sci"},{"key":"282_CR41","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1037\/0021-843X.86.2.103","volume":"86","author":"J Zubin","year":"1977","unstructured":"Zubin J, Spring B (1977) Vulnerability\u2013a new view of schizophrenia. J Abnorm Psychol 86:103\u2013126","journal-title":"J Abnorm Psychol"}],"container-title":["European Archives of Psychiatry and Clinical Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0282-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00406-011-0282-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00406-011-0282-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T17:03:44Z","timestamp":1561050224000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00406-011-0282-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,14]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["282"],"URL":"https:\/\/doi.org\/10.1007\/s00406-011-0282-7","relation":{},"ISSN":["0940-1334","1433-8491"],"issn-type":[{"value":"0940-1334","type":"print"},{"value":"1433-8491","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,14]]}}}